Gordon D, Cohen H N, Beastall G H, Perry B, Thomson J A
University Department of Medicine, Royal Infirmary, Glasgow, U.K.
J Endocrinol Invest. 1988 Feb;11(2):77-83. doi: 10.1007/BF03350106.
Twenty-two boys (9 with delayed puberty and 13 with short stature) ages 12.3 - 17.8 yr, and 10 adult males with idiopathic hypogonadotropic hypogonadism (ages 17.3 - 41.1 yr) have been studied following pulsatile, sc GnRH therapy (240 ng/kg/pulse) over 6 days. Mean pre- and post-therapy LH and FSH concentrations were estimated by 15 min blood sampling over 3-h periods immediately before and at the end of the treatment period. There were significant correlations between the mean pre- and posttreatment LH and FSH concentrations (r = 0.82, p less than 0.001 and r = 0.51, p less than 0.02, respectively) for the 2 groups of peripubertal boys when assessed together. Nine of the 10 adults with hypogonadism showed proportionately greater gonadotropin increments following pulsatile therapy when compared with the peripubertal boys. Standard bolus GnRH tests (100 micrograms iv) did not differentiate between the three groups of patients before pulsatile GnRH therapy. Bolus GnRH tests could predict the subsequent response to pulsatile therapy in the peripubertal boys only. There was no significant change in LH increments following the GnRH bolus tests in either group, after pulsatile GnRH administration (p greater than 0.1). Early response to pulsatile GnRH administration is dependent upon the maturity of the hypothalamic-pituitary-testicular axis in males with delayed puberty or short stature. Patients with hypogonadotropic hypogonadism do not show this relationship.
对22名年龄在12.3至17.8岁之间的男孩(9名青春期延迟,13名身材矮小)以及10名患有特发性低促性腺激素性性腺功能减退的成年男性(年龄在17.3至41.1岁之间)进行了研究,他们接受了为期6天的脉冲式皮下注射促性腺激素释放激素(GnRH)治疗(240 ng/kg/脉冲)。在治疗期开始前和结束时,通过在3小时内每隔15分钟采集一次血样,估算治疗前后促黄体生成素(LH)和促卵泡生成素(FSH)的平均浓度。将两组青春期前男孩的数据合并评估时,治疗前后LH和FSH的平均浓度之间存在显著相关性(r分别为0.82,p<0.001和r为0.51,p<0.02)。1名患有性腺功能减退的成年男性中,有9名在脉冲式治疗后促性腺激素的增量相比青春期前男孩成比例地更大。在脉冲式GnRH治疗前,标准剂量的GnRH试验(静脉注射100微克)无法区分这三组患者。大剂量GnRH试验仅能预测青春期前男孩对脉冲式治疗的后续反应。在脉冲式GnRH给药后,两组在GnRH大剂量试验后LH增量均无显著变化(p>0.1)。青春期延迟或身材矮小的男性对脉冲式GnRH给药的早期反应取决于下丘脑-垂体-睾丸轴的成熟度。患有低促性腺激素性性腺功能减退的患者则不存在这种关系。